We read with interest the study by David Cunningham and colleagues1 on peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma.
http://ift.tt/2oVpML6
Τρίτη 2 Μαΐου 2017
[Correspondence] Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου